Laura Flavell, PhD, — 
Articles by Laura Flavell
Recent Posts
- Takeda acquires license to ALS therapy aimed at toxic TDP-43
- Living with ALS means unraveling my concept of time
- Trial of brain-computer interface device for ALS now enrolling
- PrimeC, potential ALS therapy, earns patents in Europe, Japan, Israel
- FDA advisory committee votes against NurOwn approval for ALS